Rank: 69 (Previous rank: N.A.)
CEO: Jan Keltjens
Headquarters: Queensbury, NY
Industry: Health Care
Revenue: $180.3 million
(four quarters to 12/31/08)
Return to investors: -18.76%
(three years to 12/81/08, annualized rate)
Angiodynamics develops medical devices that enable minimally invasive treatment of cancer and peripheral vascular disease. Early this year, the company added to its product line an infusion catheter that delivers drugs through the renal arteries directly to the kidneys. Its new NanoKnife technology also holds promise for the focal treatment of cancer tumors.
... What Readers Say
They speak out on the fastest-growing small public companies ...
|Executive||2008 Total Compensation
Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.
Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.
Factset: FactSet Research Systems Inc. 2014. All rights reserved.
Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.
Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.